DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.
暂无分享,去创建一个
D. Mora | G. Roda | E. Casagni | S. Arioli | C. Rusconi | V. Gambaro | S. Arnoldi | L. Dell'acqua | F. Faré | G. L. Visconti | Eleonora Paladino
[1] K. Stebelska. Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol: Analytical Methods and Biologic Activities , 2013, Therapeutic drug monitoring.
[2] Matthew W. Johnson,et al. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects , 2011, Psychopharmacology.
[3] Felix Hasler,et al. Effects of psilocybin on time perception and temporal control of behaviour in humans , 2007, Journal of psychopharmacology.
[4] R. Griffiths,et al. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance , 2006, Psychopharmacology.
[5] D. N. Sims,et al. The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′‐bipyridyl)ruthenium(II) Chemiluminescence Detection System , 2006, Journal of forensic sciences.
[6] L. Jespersen,et al. Occurrence and diversity of yeasts involved in fermentation of West African cocoa beans. , 2005, FEMS yeast research.
[7] Felix Hasler,et al. Acute psychological and physiological effects of psilocybin in healthy humans : a double-blind , placebo-controlled dose – effect study , 2004 .
[8] R. Sugita,et al. Morphological and chemical analysis of magic mushrooms in Japan. , 2003, Forensic science international.
[9] H. Emrich,et al. The pharmacology of psilocybin , 2002, Addiction biology.
[10] F. Musshoff,et al. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. , 2000, Forensic science international.
[11] F. Vollenweider,et al. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. , 1997, Pharmaceutica acta Helvetiae.
[12] J. Gartz. Extraction and analysis of indole derivatives from fungal biomass , 1994, Journal of basic microbiology.
[13] M. Wurst,et al. Analysis and isolation of indole alkaloids of fungi by high-performance liquid chromatography , 1992 .
[14] R. Brenneisen,et al. Determination of tryptamine derivatives in hallucinogenic mushrooms using high-performance liquid chromatography with photodiode array detection. , 1987, Journal of chromatography.
[15] J. Vokoun,et al. Analysis of psychotropic compounds in fungi of the genus psilocybe by reversed-phase high-performance liquid chromatography , 1984 .
[16] M. Beug,et al. Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography. , 1981, Journal of chromatography.
[17] A. Horita,et al. Dephosphorylation of psilocybin in the intact mouse. , 1962, Toxicology and applied pharmacology.
[18] A. Horita,et al. The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates. , 1961, Biochemical pharmacology.
[19] A. Horita,et al. Dephosphorylation of Psilocybin to Psilocin by Alkaline Phosphatase , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.